Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Surviving and Thriving During Challenging Times
COVID-19 has changed our world...literally.
Mitchell
Article
Current Used Vehicle Market Conditions: Q1 2020
March and April 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
Workers' Comp
Article
CMS to Add Correspondence Printing Functionality to the Medicare Conditional Payment Portal
Keep current with new legislation and its potential effect on your organization.
Mitchell
Article
Total Loss Trends Emerge Amidst the Pandemic
Every industry has been impacted by actions taken to control the spread of COVID-19, including the automotive industry.
Workers' Comp
Blog
Networks Support Telemedicine for Continued Care
“Our offices are temporarily closed due to COVID-19.”This is the message many people received when contacting th
Auto Physical Damage
Article
Reduce In-Person Interactions and Improve Efficiency with Virtual Claims
In March, Ryan Mandell, director of Claims Performance for Mitchell’s Auto Physical Damage business unit, identified the market drivers converging